Article Versions Notes

Barbato A, Iuliano A, Volpe M, D’Alterio R, Brillante S, Massa F, De Cegli R, Carrella S, Salati M, Russo A, et al. Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma. International Journal of Molecular Sciences. 2021; 22(4):1801. https://doi.org/10.3390/ijms22041801

Barbato, Anna, Antonella Iuliano, Mariagrazia Volpe, Romina D’Alterio, Simona Brillante, Filomena Massa, Rossella De Cegli, Sabrina Carrella, Massimiliano Salati, Annapina Russo, and et al. 2021. "Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma" International Journal of Molecular Sciences 22, no. 4: 1801. https://doi.org/10.3390/ijms22041801

Barbato, A., Iuliano, A., Volpe, M., D’Alterio, R., Brillante, S., Massa, F., De Cegli, R., Carrella, S., Salati, M., Russo, A., Russo, G., Riccardo, S., Cacchiarelli, D., Capone, M., Madonna, G., Ascierto, P. A., Franco, B., Indrieri, A., & Carotenuto, P. (2021). Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma. International Journal of Molecular Sciences, 22(4), 1801. https://doi.org/10.3390/ijms22041801